Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa

Intensive Care Medicine

Volumn 35, Issue 10, 2009, Pages 1792-1800

  Ferrari, Fabio ^a,b   Lu, Qin ^a,b   Girardi, Cassio ^c   Petitjean, Olivier ^d   Marquette, Charles Hugo ^e   Wallet, Frederic ^f   Rouby, Jean Jacques ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d AVICENNE HOSPITAL   (France)

^e INSERM   (France)

^f UNIVERSITÉ LILLE 1   (France)

Author keywords

Ceftazidime; Mechanical ventilation; Nebulization; Pneumonia; Pseudomonas aeruginosa; Treatment

Indexed keywords

CEFTAZIDIME;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG SENSITIVITY; HISTOPATHOLOGY; LUNG PARENCHYMA; MINIMUM INHIBITORY CONCENTRATION; NEBULIZATION; NONHUMAN; PIGLET; PSEUDOMONAS AERUGINOSA; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 72449125618     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-009-1605-2     Document Type: Article

References (39)

1. JL Vincent DJ Bihari PM Suter HA Bruining J White MH Nicolas-Chanoin M Wolff RC Spencer M Hemmer 1995 The prevalence of nosocomial infection in intensive care units in Europe Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee JAMA 274 639 644 7637145 10.1001/jama.274.8.639 1:STN:280:DyaK2MzmsVWnuw%3D%3D
2. DC Bergmans MJ Bonten CA Gaillard FH van Tiel S van der Geest PW de Leeuw EE Stobberingh 1997 Indications for antibiotic use in ICU patients: a 1-year prospective surveillance J Antimicrob Chemother 39 527 535 9145828 10.1093/jac/39.4.527 1:CAS:528:DyaK2sXjtlygs78%3D
3. N Mesaros P Nordmann P Plesiat M Roussel-Delvallez J Van Eldere Y Glupczynski Y Van Laethem F Jacobs P Lebecque A Malfroot PM Tulkens F Van Bambeke 2007 Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium Clin Microbiol Infect 13 560 578 17266725 10.1111/j.1469-0691.2007.01681.x 1:CAS:528:DC%2BD2sXms1Oksbs%3D (Pubitemid 46730662)
4. MD Obritsch DN Fish R MacLaren R Jung 2005 Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options Pharmacotherapy 25 1353 1364 16185180 10.1592/phco.2005.25.10.1353 1:CAS:528:DC%2BD2MXhtFGitbzE (Pubitemid 41407633)
5. JD Cavallo F Leblanc R Fabre 2000 Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study Pathol Biol (Paris) 48 472 477 1:CAS:528: DC%2BD3cXlvVymur4%3D
6. L Alou L Aguilar D Sevillano MJ Gimenez O Echeverria ML Gomez-Lus J Prieto 2005 Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model J Antimicrob Chemother 55 209 213 15650000 10.1093/jac/dkh536 1:CAS:528:DC%2BD2MXovVyqtQ%3D%3D (Pubitemid 40331147)
7. C Girardi M Tonnellier I Goldstein A Sartorius F Wallet JJ Rouby 2006 Lung deposition of continuous and intermittent intravenous ceftazidime in experimental Pseudomonas aeruginosa bronchopneumonia Intensive Care Med 32 2042 2048 16858611 10.1007/s00134-006-0272-9 1:CAS:528:DC%2BD1cXhtVOktbjO (Pubitemid 44833119)
8. I Goldstein F Wallet J Robert MH Becquemin CH Marquette JJ Rouby 2002 Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs Am J Respir Crit Care Med 165 171 175 11790649
9. Rouby JJ, Goldstein I, Lu Q (2006) Inhaled antibiotic therapy. In: Tobin MJ (ed) Principles and practice of mechanical ventilation, chap 64, 2nd edn. McGraw-Hill Medical Publishing Division, New York, pp 1311-1332
10. I Goldstein F Wallet A Nicolas-Robin F Ferrari CH Marquette JJ Rouby 2002 Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets Am J Respir Crit Care Med 166 1375 1381 12406838 10.1164/rccm.200204-363OC (Pubitemid 35292705)
11. M Tonnellier F Ferrari I Goldstein A Sartorius CH Marquette JJ Rouby 2005 Intravenous versus nebulized ceftazidime in ventilated piglets with and without experimental bronchopneumonia: comparative effects of helium and nitrogen Anesthesiology 102 995 1000 15851887 10.1097/00000542-200505000-00019 1:CAS:528:DC%2BD2MXjsFKgt7w%3D (Pubitemid 40586541)
12. F Ferrari ZH Liu Q Lu MH Becquemin K Louchahi G Aymard CH Marquette JJ Rouby 2008 Comparison of lung tissue concentrations of nebulized ceftazidime in ventilated piglets: ultrasonic versus vibrating plate nebulizers Intensive Care Med 34 1718 1723 18542922 10.1007/s00134-008-1126-4
13. CM Myers JL Blumer 1983 Determination of ceftazidime in biological fluids by using high-pressure liquid chromatography Antimicrob Agents Chemother 24 343 346 6357075 1:CAS:528:DyaL3sXlvVKqs70%3D
14. E Dahlberg 1983 Estimation of the blood contamination of tissue extracts Anal Biochem 130 108 113 6869792 10.1016/0003-2697(83)90656-5 1:CAS:528:DyaL3sXhslGktbk%3D
15. VS Baselski RG Wunderink 1994 Bronchoscopic diagnosis of pneumonia Clin Microbiol Rev 7 533 558 7834604 1:STN:280:DyaK2M7js1ajtQ%3D%3D
16. M Elman I Goldstein CH Marquette F Wallet G Lenaour JJ Rouby 2002 Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia Anesthesiology 97 199 206 12131123 10.1097/00000542-200207000-00028 1:CAS:528:DC%2BD38XlslSqur8%3D (Pubitemid 34733941)
17. A Agodi M Barchitta R Cipresso L Giaquinta MA Romeo C Denaro 2007 Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients Intensive Care Med 33 1155 1161 17503016 10.1007/s00134-007-0671-6 (Pubitemid 47036900)
18. RK Flamm MK Weaver C Thornsberry ME Jones JA Karlowsky DF Sahm 2004 Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002 Antimicrob Agents Chemother 48 2431 2436 15215091 10.1128/AAC.48.7.2431-2436.2004 1:CAS:528:DC%2BD2cXlsFWmtrg%3D (Pubitemid 38823407)
19. E Boselli D Breilh T Rimmele JC Poupelin MC Saux D Chassard B Allaouchiche 2004 Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia Intensive Care Med 30 989 991 14985960 10.1007/s00134-004-2171-2 (Pubitemid 38639498)
20. JW Mouton JG den Hollander 1994 Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model Antimicrob Agents Chemother 38 931 936 8067772 1:CAS:528:DyaK2cXktVSgsr4%3D
21. DE Nix SD Goodwin CA Peloquin DL Rotella JJ Schentag 1991 Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response Antimicrob Agents Chemother 35 1953 1959 1759813 1:CAS:528: DyaK3MXmt1alsrY%3D
22. DM Ryan O Cars 1983 A problem in the interpretation of beta-lactam antibiotic levels in tissues J Antimicrob Chemother 12 281 284 6630113 10.1093/jac/12.3.281 1:CAS:528:DyaL3sXmtVGmt7o%3D
23. DE Nix SD Goodwin CA Peloquin DL Rotella JJ Schentag 1991 Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning Antimicrob Agents Chemother 35 1947 1952 1759812 1:CAS:528: DyaK3MXmt1alsrk%3D
24. S Bayat K Louchahi B Verdiere D Anglade A Rahoui PM Sorin M Tod O Petitjean F Fraisse FA Grimbert 2004 Comparison of 99mTc-DTPA and urea for measuring cefepime concentrations in epithelial lining fluid Eur Respir J 24 150 156 15293618 10.1183/09031936.04.00106803 1:CAS:528:DC%2BD2cXmsVanu7o%3D (Pubitemid 39029081)
25. AE Talor AC Guyton VS Bishop 1965 Permeability of the alveolar membrane to solutes Circ Res 16 353 362
26. FM Gengo JJ Schentag WJ Jusko 1984 Pharmacokinetics of capacity-limited tissue distribution of methicillin in rabbits J Pharm Sci 73 867 873 6470946 10.1002/jps.2600730703 1:CAS:528:DyaL2cXks1Gmsbo%3D
27. DR Baldwin R Wise JM Andrews D Honeybourne 1992 Concentrations of cefpodoxime in serum and bronchial mucosal biopsies J Antimicrob Chemother 30 67 71 1429338 10.1093/jac/30.1.67 1:STN:280:DyaK3s%2FlsVWqug%3D%3D
28. I Goldstein MT Bughalo CH Marquette G Lenaour Q Lu JJ Rouby 2001 Mechanical ventilation-induced air-space enlargement during experimental pneumonia in piglets Am J Respir Crit Care Med 163 958 964 11282773 1:STN:280:DC%2BD3M3ntFOluw%3D%3D
29. D Wermert CH Marquette MC Copin F Wallet A Fraticelli P Ramon AB Tonnel 1998 Influence of pulmonary bacteriology and histology on the yield of diagnostic procedures in ventilator-acquired pneumonia Am J Respir Crit Care Med 158 139 147 9655720 1:STN:280:DyaK1czisFaqtw%3D%3D
30. N Fabregas A Torres M El-Ebiary J Ramirez C Hernandez J Gonzalez J de la Bellacasa J de Anta R Rodriquez-Roisin 1996 Histopathologic and microbiologic aspects of ventilator-associated pneumonia Anesthesiology 84 757 759 10.1097/00000542-199604000-00002 (Pubitemid 26105238)
31. JJ Rouby E Martin De Lassale P Poete MH Nicolas L Bodin V Jarlier Y Le Charpentier J Grosset P Viars 1992 Nosocomial bronchopneumonia in the critically ill histologic and bacteriologic aspects Am Rev Respir Dis 146 1059 1066 1416397 1:STN:280:DyaK3s%2Fjs1Omug%3D%3D
32. AR Hauser 2008 Pseudomonas aeruginosa: an uninvited guest refuses to leave Am J Respir Crit Care Med 178 438 439 18713847 10.1164/rccm.200805-789ED
33. J Rello D Mariscal F March P Jubert F Sanchez J Valles P Coll 1998 Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection? Am J Respir Crit Care Med 157 912 916 9517611 1:STN:280: DyaK1c7ns1Orug%3D%3D
34. S Visscher CA Schurink WG Melsen PJ Lucas MJ Bonten 2008 Effects of systemic antibiotic therapy on bacterial persistence in the respiratory tract of mechanically ventilated patients Intensive Care Med 34 692 699 18180901 10.1007/s00134-007-0984-5
35. J Valles D Mariscal P Cortes P Coll A Villagra E Diaz A Artigas J Rello 2004 Patterns of colonization by Pseudomonas aeruginosa in intubated patients: a 3-year prospective study of 1,607 isolates using pulsed-field gel electrophoresis with implications for prevention of ventilator-associated pneumonia Intensive Care Med 30 1768 1775 15243686 10.1007/s00134-004-2382-6 (Pubitemid 39297181)
36. H Kobayashi 2005 Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections Treat Respir Med 4 241 253 16086598 10.2165/00151829-200504040-00003 1:CAS:528:DC%2BD2MXhtV2itrjF (Pubitemid 41252835)
37. AA El Solh ME Akinnusi JP Wiener-Kronish SV Lynch LA Pineda K Szarpa 2008 Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia Am J Respir Crit Care Med 178 513 519 18467510 10.1164/rccm.200802- 239OC
38. LB Palmer GC Smaldone JJ Chen D Baram T Duan M Monteforte M Varela AK Tempone T O'Riordan F Daroowalla P Richman 2008 Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit Crit Care Med 36 2008 2013 18552684 10.1097/CCM.0b013e31817c0f9e 1:CAS:528: DC%2BD1cXotVyls7k%3D
39. ME Falagas II Siempos IA Bliziotis A Michalopoulos 2006 Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials Crit Care 10 R123 16934148 10.1186/cc5032 (Pubitemid 47086878)